[ad_1]
Investing.com – Biondvax Pharma ADR reported on Wednesday third quarter that beat analysts’ forecasts and income that was inline with expectations.
Biondvax Pharma ADR introduced earnings per share of $0.003 on income of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.100 on income of $0.00.
Biondvax Pharma ADR shares are down 61.11% from the start of the yr and are buying and selling at $9.140 , down-from-52-week-high.
Biondvax Pharma ADR shares misplaced 2.35% in intra-day commerce the report.
Biondvax Pharma ADR follows different main Healthcare sector earnings this month
Biondvax Pharma ADR’s report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on income of $6.94B, in comparison with forecasts EPS of $1.91 on income of $6.91B.
Novo Nordisk ADR had beat expectations on Wednesday, November 2, 2022 with third quarter EPS of $0.8409 on income of $6.04B, in comparison with forecast for EPS of $0.837 on income of $6.04B.
Keep up-to-date on all the upcoming earnings studies by visiting Investing.com’s earnings calendar
[ad_2]
Source link